Cellosaurus logo
expasy logo

Cellosaurus SK-MEL-204 (CVCL_U909)

[Text version]
Cell line name SK-MEL-204
Accession CVCL_U909
Resource Identification Initiative To cite this cell line use: SK-MEL-204 (RRID:CVCL_U909)
Comments From: Memorial Sloan Kettering Cancer Center; New York; USA.
Sequence variations
  • Gene deletion; HGNC; 1787; CDKN2A; Zygosity=Homozygous (PubMed=9598804).
  • Gene deletion; HGNC; 1788; CDKN2B; Zygosity=Homozygous (PubMed=9598804).
Disease Amelanotic melanoma (NCIt: C3802)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Category Cancer cell line
Publications

PubMed=1716514
Albino A.P., Davis B.M., Nanus D.M.
Induction of growth factor RNA expression in human malignant melanoma: markers of transformation.
Cancer Res. 51:4815-4820(1991)

PubMed=7509835; DOI=10.1111/1523-1747.ep12371784
Bouchard B., Vijayasaradhi S., Houghton A.N.
Production and characterization of antibodies against human tyrosinase.
J. Invest. Dermatol. 102:291-295(1994)

PubMed=9598804; DOI=10.1002/(SICI)1098-2264(199806)22:2<157::AID-GCC11>3.0.CO;2-N
Walker G.J., Flores J.F., Glendening J.M., Lin A.H.-T., Markl I.D.C., Fountain J.W.
Virtually 100% of melanoma cell lines harbor alterations at the DNA level within CDKN2A, CDKN2B, or one of their downstream targets.
Genes Chromosomes Cancer 22:157-163(1998)

Cross-references
Encyclopedic resources Wikidata; Q54953916
Entry history
Entry creation16-Apr-2014
Last entry update30-Jan-2024
Version number7